Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer

Journal of Urology

Volumn 162, Issue 3 I, 1999, Pages 922-926

  Afonso, Anoushka ^b   Emmert Buck, Michael R ^b   Duray, Paul H ^b   Bostwick, David G ^b   Linehan, W Marston ^b   Vocke, Cathy D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

Human chromosome 13; Loss of heterozygosity; Prostate carcinoma; Tissue microdissection; Tumor suppressor gene

Indexed keywords

DNA; PROSTATE SPECIFIC ANTIGEN;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CHROMOSOME 13Q; CLINICAL ARTICLE; CONTROLLED STUDY; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR SUPPRESSOR GENE;

EID: 0032882520     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-199909010-00091     Document Type: Article

References (16)

1. Landis, S. H., Murray, T., Bolden, S. and Wingo, P. A.: Cancer Statistics, 1998. CA Cancer J. Clin., 48: 6, 1998.
2. Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J., Brooks, J. D. and Ewing, C. M.: Molecular biology of prostate cancer. Semin. Oncol., 21: 514, 1994.
3. Carter, B. S., Ewing, C. M., Ward, W. S., Treiger, B. F., Aalders, T. W., Schalken, J. A., Epstein, J. I. and Isaacs, W. B.: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc. Natl. Acad. Sci. USA, 87: 8751, 1990.
4. Bergerheim, U. S., Kunimi, K., Collins, V. P. and Ekman, P.: Deletion mapping of chromosomes 8, 10, and 16 in human prostatic carcinoma. Genes Chromosom. Cancer, 3: 215, 1991.
5. Phillips, S. M., Barton, C. M., Lee, S. J., Morton, D. G., Wallace, D. M., Lemoine, N. R. and Neoptolemos, J. P.: Loss of the retinoblastoma susceptibility (RB1) is a frequent and early event in prostate tumorigenesis. Br. J. Cancer, 70: 1252, 1994.
6. Brooks, J. D., Bova, G. S. and Isaacs, W. B.: Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate, 26: 35, 1995.
7. Ittmann, M. M. and Wieczorek, R.: Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas. Hum. Pathol., 27: 28, 1996.
8. Cooney, K., Wetzel, J. C., Merajver, S. D., Macoska, J. A., Singleton, T. P. and Wojno, K. J.: Distinct regions of allelic loss on 13q in prostate cancer. Cancer Res., 56: 1142, 1996.
9. Li, C., Larsson, C., Futreal, A., Lancaster, J., Phelan, C., Aspenblad, U., Sundelin, B., Liu, Y., Ekman, P., Auer, G. and Bergerheim, U. S.: Identification of two distinct deleted regions on chromosome 13 in prostate cancer. Oncogene, 16: 481, 1998.
10. Emmert-Buck, M. R., Roth, M. J., Zhuang, Z., Campo, E., Rozhin, J., Sloane, B. F., Liotta, L. A. and Stetler-Stevenson, W. G.: Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am. J. Pathol., 145: 1285, 1994.
11. Vocke, C. D., Pozzatti, R. O., Bostwick, D. G., Florence, C. D., Jennings, S. B., Strup, S. E., Duray, P. H., Liotta, L. A, Emmert-Buck, M. R. and Linehan, W. M.: Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21. Cancer Res., 56: 2411, 1996.
12. Lee, W. H., Bookstein, R., Hong, F., Young, L. J., Shew, J. Y. and Lee, E. Y.: Human retinoblastoma susceptibility gene: cloning, identification, and sequence. Science, 235: 1394, 1987.
13. Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J. and Weissenbach, J.: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature, 380: 152, 1996.
14. Cunningham, J. M., Shan, A., Wick, M. J., McDonnell, S. K., Schaid, D. J., Tester, D. J., Qian, J., Takahashi, S., Jenkins, R. B., Bostwick, D. G. and Thibodeau, S. N.: Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. Cancer Res., 56: 4475, 1996.
15. Dahiya, R., Lee, C., McCarville, J., Hu, W., Kaur, G. and Deng, G.: High frequency of genetic instability of microsatellites in human prostatic adenocarcinoma. Int. J. Cancer, 72: 762, 1997.
16. Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E. and Lee, W. H.: Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA, 87: 7762, 1990.